EUVIMEDEUVIMED entdecken
Crossref

S100P binds to RAGE and activates ERK/NF-κB signaling to promote osteoclast differentiation and activity

Seung-Hoon Lee, Na Rae Park, Eui Kyun Park, Jung-Eun Kim

Biochemical and Biophysical Research Communications · 2024

DOI: 10.1016/j.bbrc.2024.150536 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2024. Verfasst von Seung-Hoon Lee und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Medicine, Cell and Matrix Research Institute, School of Medicine, Kyungpook National University, Daegu, 41944, Republic of Ko…. Hauptthemen laut MEDLINE: Osteoclasts, Cell Differentiation, Receptor for Advanced Glycation End Products, NF-kappa B. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: National Research Foundation of Korea, Ministry of Science, ICT and Future Planning.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

S100 calcium-binding protein P (S100P) is a secretory protein that is expressed in various healthy tissues and tumors. Megakaryocyte-secreted S100P promotes osteoclast differentiation and function; however, its receptor and cellular signaling in osteoclasts remain unclear. Receptor for advanced glycation end products (RAGE), which is the receptor for S100P on cancer cells, was expressed in osteoclast precursors, and S100P-RAGE binding was confirmed through co-immunoprecipitation. Additionally, the phosphorylation of ERK and NF-κB was increased in S100P-stimulated osteoclast precursors but was inhibited by addition of the RAGE antagonistic peptide (RAP). S100P-induced osteoclast differentiation and excessive bone resorption activity were also reduced by the addition of RAP. This study demonstrates that S100P, upon binding with RAGE, activates the ERK and NF-κB signaling pathways in osteoclasts, leading to increased cell differentiation and bone resorption activity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteoclastsCell DifferentiationReceptor for Advanced Glycation End ProductsNF-kappa BBone ResorptionSignal TransductionProtein BindingAnimalsMiceHumansMAP Kinase Signaling SystemMice, Inbred C57BLCells, CulturedNeoplasm ProteinsExtracellular Signal-Regulated MAP Kinases

Stichwörter der Autor:innen

OsteoclastsReceptor for advanced glycation end productsS100 calcium-binding protein P

Substanzen

Receptor for Advanced Glycation End ProductsNF-kappa BNeoplasm ProteinsExtracellular Signal-Regulated MAP Kinases

Autor:innen und Institutionen

  • Department of Molecular Medicine, Cell and Matrix Research Institute, School of Medicine, Kyungpook National University, Daegu, 41944, Republic of Korea.
  • Department of Oral Pathology and Regenerative Medicine, School of Dentistry, Kyungpook National University, Daegu, 41944, Republic of Korea.
  • Department of Molecular Medicine, Cell and Matrix Research Institute, School of Medicine, Kyungpook National University, Daegu, 41944, Republic of Korea; BK21 Four KNU Convergence Educational Program of Biomedical Scien…

Förderung

  • National Research Foundation of Korea
  • Ministry of Science, ICT and Future Planning

Zitieren

APA

Lee, S. H., Park, N. R., Park, E. K., & Kim, J. E. (2024). S100P binds to RAGE and activates ERK/NF-κB signaling to promote osteoclast differentiation and activity. Biochemical and Biophysical Research Communications. https://doi.org/10.1016/j.bbrc.2024.150536

Vancouver

Lee SH, Park NR, Park EK, Kim JE. S100P binds to RAGE and activates ERK/NF-κB signaling to promote osteoclast differentiation and activity. Biochemical and Biophysical Research Communications. 2024. doi:10.1016/j.bbrc.2024.150536

BibTeX
@article{Lee2024,
  author = {Lee, Seung-Hoon and Park, Na Rae and Park, Eui Kyun and Kim, Jung-Eun},
  title = {S100P binds to RAGE and activates ERK/NF-κB signaling to promote osteoclast differentiation and activity},
  journal = {Biochemical and Biophysical Research Communications},
  year = {2024},
  doi = {10.1016/j.bbrc.2024.150536}
}
Kostenlos starten →